Abstract
PURPOSE: While randomized controlled trials (RCTs) comparing pharmacologic regimens for venous thromboembolism (VTE) prophylaxis following orthopaedic surgeries have demonstrated differences in efficacy, these studies are criticized because they focus on venographic endpoints. We sought to confirm the findings of RCTs and to determine if differences noted in RCTs translate into “real-world” clinical outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
